Diogo Rau

speaker
67 appearances 1 recordings 1 series first heard Feb 2025 last heard Feb 2025

Diogo Rau’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months
No recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.

Appearances

newest first · ▶ plays the moment
And I think this whole industry hasn't really focused on like, how do we make it an amazing experience and work backwards? I think the kinds of things that you see at Apple and a lot of other consumer-oriented companies just haven't arrived here yet. And how does putting the customer...
That was the most fundamental thing that I learned from my time at Apple. And I think most companies will say, oh, we care about the customer. But whenever you start a project, People will have, I don't know, they'll have five pillars or five things they need to go after. Well, maybe there's the business case, the product, the customer, you know, you'll have like five or six different things.
And the way you'd always do things at Apple was different. You would always start by like, what's the customer, the consumer experience that you want to create? and then work backwards and then figure out, can you make it a financial case around it? Well, maybe you can't. Okay, so maybe we can see how we can change things back and forth. But everything was centered on the customer experience.
It wasn't like a pillar of one thing of five. It was like the thing that was guiding everything. And I think that's, we're not there yet, but that's the kind of thing we need to do every single time. We need to go back and see what's the customer experience like. We need to actually focus on making a customer experience better. Yeah, yeah.
Okay. Great.
share with everybody that, like, Malcolm and I had a little prep call before, you know, a couple weeks ago, and it was only about 10 minutes because he just said, okay, you know, if you've got any toys, any goodies, like, bring them along. And so, like, my team gave me a box of goodies here, which is all splayed out on the table. And then I think he said, okay, I don't want to talk too much more.
Let's not do any more prep. Let's just get going.
That would be the only thing that was top of mind. Awesome. All right. So let me grab a box. All right. I'm going to show you something that is... No, let me grab that one. Yep. And I'm going to hide it here for just a second and tell you what the problem is that we're going after. One of the big challenges in the world right now is medicine and medicine safety.
When I was at Apple, I saw counterfeit iPhones and I couldn't believe it. You wouldn't know that they were counterfeit until you actually picked them up and played with them for like half an hour. And sometimes we'd have to send them in and have them get x-rayed to know that they're fake. Well, those were on products. That was like a $1,000 product, electronics.
Very hard to make a counterfeit, but the economics were there. Medicines are a lot easier to fake, or at least make them look fake. All you need to do is copy the box, and if it's in a vial, put a label on it, something like that.
And with some of the medicines that are out there right now, there's a huge financial incentive for people to say that they're making medicines that they really are not, and they're faking them.
Well, right now, in chronic weight management, we have the GLP-1 medicines. And so, both for us and the other leading maker of GLP-1 medicines... Counterfeiting is a real, real threat. And back to formularies and things like that, a lot of insurance plans do not cover chronic weight loss management.
And so there's a huge financial incentive on the black market to say, hey, we're going to go... And some uncertainty about outcomes. So it would take you a while to figure out you're taking a fake. Correct. And I mean, it's not only...
I mean, it's not only fake, it's actually, many of these cases are risky because once you see, once you see like the sterile environments that these medicines go through to be made, you know, that it could, in the best case, it's harmless, right? I mean, the best case is you don't get any effect. And so what I've got here is a product. I'm going to, this can be any product.
And so don't pay attention to what product this actually is. And I've got the product right here and I can tap my phone against it and I will get it in an NFC tag. And that NFC tag is just like when you do a contactless payment. And it will bring up a page to show you that could actually verify that the packaging matches something that we've produced. Unlike a QR code, it can't be copied.
It's cryptographically secure. And this is where the technology part gets interesting because they can copy the box. They can do all kinds of things like that, but they can't copy that tag. There's one and only one tag that you can tap and then we can verify it.
So this is something we did within my first few months of coming here. And we haven't launched it yet. So the designing it is very easy. The developing it is very hard.
Correct. And the manufacturer. That's absolutely right. And, you know, we actually don't even care about it necessarily being just for us. Like, this is the kind of thing where we'd say, this is a great thing if adherence can improve for patients across all medicines, all manufacturers, that would be fantastic.
So this is version one, which is on the box. And then version two, which we'll come to later, will be on the individual medicine itself.
Absolutely. Then you could actually make sure that you're taking the right medicine. I also think making sure that you haven't taken your medicine more than once in a day is also an important thing because you know what? It's actually very easy to do.
Showing 21–40 of 67 · page 2 of 4 ← Previous Next →